Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
8 pending office actions • 8 art units • 8 examiners • 0 of 8 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
VERSITECH Limited has 8 pending office actions in Biotechnology & Pharmaceuticals. The portfolio involves 8 distinct examiners and 8 distinct art units, indicating that each pending matter is assigned through a separate examiner and art-unit path.
MILLER, DALE R is the busiest examiner, with 1 pending matter. No examiner concentration exceeds that figure, so a response approach developed for one matter should not be presumed to apply across the portfolio.
Counsel should prioritize centralized docket oversight while preserving application-specific substantive analysis. The fully distributed assignments make independent review of cited art, claim construction, and amendment strategy important for each biotechnology prosecution record.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (12%) |
| §103 only | 2 (25%) |
| Multi-statute (no §101) | 5 (62%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MILLER, DALE R | 1 | 62.5% | +17.6% |
| WANG, NICHOLAS A | 1 | 53.5% | +22.1% |
| SHAH, NEEL D | 1 | 86.9% | +7.7% |
| DESTEFANO, AUDRA JEAN | 1 | 57.5% | +57.2% |
| OSINSKI, BRADLEY JAMES | 1 | 78.5% | +10.9% |
| LI, BAO Q | 1 | 75.5% | +26.7% |
| KUCHARCZK, JED A | 1 | 80.4% | +16.3% |
| RIGA, MICHAEL ANGELO | 1 | 56.2% | +63.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18686153 | FABRICATION OF A SCALABLE QUANTUM SENSING DEVICE THROUGH PRECISELY PROGRAMMABLE PATTERNING SPIN DEFECTS ON UNIVERSAL SUBSTRATES | SHAH, NEEL D | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18261991 | A STEERABLE ARM FOR USE IN ENDOSCOPIC SURGICAL PROCEDURES | OSINSKI, BRADLEY JAMES | 30d |
| 18717355 | ANTIFUNGAL COMPOUND, COMPOSITION AND USES THEREOF | MILLER, DALE R | — |
| 18708980 | ANTIBACTERIAL AND ANTIVIRAL COPPER-CONTAINING STAINLESS STEEL, AND PREPARATION METHOD THEREFOR AND USE THEREOF | WANG, NICHOLAS A | — |
| 18568727 | APPLICATION OF METALLO-SUPRAMOLECULAR BRANCHED POLYMERS IN CRYO-ELECTRON MICROSCOPY SAMPLE PREPARATION | DESTEFANO, AUDRA JEAN | — |
| 18267931 | COMPOSITIONS IMMUNOGENIC AGAINST INFLUENZA AND SARS CORONAVIRUS 2, METHODS OF MAKING AND USING THEREOF | LI, BAO Q | — |
| 17617895 | PURMORPHAMINE AS A SMALL COMPOUND POSITIVE ALLOSTERIC MODULATOR OF SECRETIN RECEPTOR FOR THE TREATMENT OF HYPERTENSION | KUCHARCZK, JED A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17434513 | RECOMBINANT VECTORS COMPRISING ARYLSULFATASE A AND THEIR USES IN STEM CELL THERAPY FOR THE TREATMENT OF METACHROMATIC LEUKODYSTROPHY | RIGA, MICHAEL ANGELO | 87d overdue |
| 18261991 | A STEERABLE ARM FOR USE IN ENDOSCOPIC SURGICAL PROCEDURES | OSINSKI, BRADLEY JAMES | 30d |
| 18717355 | ANTIFUNGAL COMPOUND, COMPOSITION AND USES THEREOF | MILLER, DALE R | — |
| 18708980 | ANTIBACTERIAL AND ANTIVIRAL COPPER-CONTAINING STAINLESS STEEL, AND PREPARATION METHOD THEREFOR AND USE THEREOF | WANG, NICHOLAS A | — |
| 18568727 | APPLICATION OF METALLO-SUPRAMOLECULAR BRANCHED POLYMERS IN CRYO-ELECTRON MICROSCOPY SAMPLE PREPARATION | DESTEFANO, AUDRA JEAN | — |
| 18267931 | COMPOSITIONS IMMUNOGENIC AGAINST INFLUENZA AND SARS CORONAVIRUS 2, METHODS OF MAKING AND USING THEREOF | LI, BAO Q | — |
| 17617895 | PURMORPHAMINE AS A SMALL COMPOUND POSITIVE ALLOSTERIC MODULATOR OF SECRETIN RECEPTOR FOR THE TREATMENT OF HYPERTENSION | KUCHARCZK, JED A | — |
| Art Unit | Apps |
|---|---|
| 1693 | 1 |
| 1734 | 1 |
| 2858 | 1 |
| 1766 | 1 |
| 3783 | 1 |
| 1671 | 1 |
| 1623 | 1 |
| 1634 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18717355 | ANTIFUNGAL COMPOUND, COMPOSITION AND USES THEREOF | MILLER, DALE R | 1693 | §101§102§103 | Non-Final OA | — | Pending | Jun 06, 2024 |
| 18708980 | ANTIBACTERIAL AND ANTIVIRAL COPPER-CONTAINING STAINLESS STEEL, AND PREPARATION METHOD THEREFOR AND USE THEREOF | WANG, NICHOLAS A | 1734 | §103§112 | Non-Final OA | — | Pending | May 09, 2024 |
| 18686153 | FABRICATION OF A SCALABLE QUANTUM SENSING DEVICE THROUGH PRECISELY PROGRAMMABLE PATTERNING SPIN DEFECTS ON UNIVERSAL SUBSTRATES | SHAH, NEEL D | 2858 | §103 | Non-Final OA | — | Pending | Feb 23, 2024 |
| 18568727 | APPLICATION OF METALLO-SUPRAMOLECULAR BRANCHED POLYMERS IN CRYO-ELECTRON MICROSCOPY SAMPLE PREPARATION | DESTEFANO, AUDRA JEAN | 1766 | §102§103§112 | Non-Final OA | — | Pending | Dec 08, 2023 |
| 18261991 | A STEERABLE ARM FOR USE IN ENDOSCOPIC SURGICAL PROCEDURES | OSINSKI, BRADLEY JAMES | 3783 | §103§112 | Final Rejection | 30d | Pending | Jul 18, 2023 |
| 18267931 | COMPOSITIONS IMMUNOGENIC AGAINST INFLUENZA AND SARS CORONAVIRUS 2, METHODS OF MAKING AND USING THEREOF | LI, BAO Q | 1671 | §102§103§112 | Non-Final OA | — | Pending | Jun 16, 2023 |
| 17617895 | PURMORPHAMINE AS A SMALL COMPOUND POSITIVE ALLOSTERIC MODULATOR OF SECRETIN RECEPTOR FOR THE TREATMENT OF HYPERTENSION | KUCHARCZK, JED A | 1623 | §102§103§112 | Final Rejection | — | Pending | Dec 09, 2021 |
| 17434513 | RECOMBINANT VECTORS COMPRISING ARYLSULFATASE A AND THEIR USES IN STEM CELL THERAPY FOR THE TREATMENT OF METACHROMATIC LEUKODYSTROPHY | RIGA, MICHAEL ANGELO | 1634 | §103 | Final Rejection | 87d overdue | Pending | Aug 27, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialVERSITECH Limited has 8 pending office actions as of October 2026, spread across 8 art units and 8 examiners.
Dale R Miller has the most, with 1 of VERSITECH Limited's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
